| Record Information |
|---|
| Version | 1.0 |
|---|
| Creation Date | 2016-05-19 01:52:58 UTC |
|---|
| Update Date | 2016-11-09 01:09:23 UTC |
|---|
| Accession Number | CHEM004629 |
|---|
| Identification |
|---|
| Common Name | ALGINATE, CALCIUM |
|---|
| Class | Small Molecule |
|---|
| Description | An organic calcium salt composed of calcium cations and atorvastatin anions in a 1:2 ratio. |
|---|
| Contaminant Sources | - EAFUS Chemicals
- FooDB Chemicals
- HPV EPA Chemicals
- OECD HPV Chemicals
- ToxCast & Tox21 Chemicals
|
|---|
| Contaminant Type | Not Available |
|---|
| Chemical Structure | |
|---|
| Synonyms | | Value | Source |
|---|
| Atorvastan | ChEBI | | Calcium (betar,deltar)-2-(p-fluorophenyl)-beta,delta-dihydroxy-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)pyrrole-1-heptanoate (1:2) | ChEBI | | Lipitor | ChEBI | | Liprimar | ChEBI | | Calcium (betar,deltar)-2-(p-fluorophenyl)-b,delta-dihydroxy-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)pyrrole-1-heptanoate (1:2) | Generator | | Calcium (betar,deltar)-2-(p-fluorophenyl)-b,delta-dihydroxy-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)pyrrole-1-heptanoic acid (1:2) | Generator | | Calcium (betar,deltar)-2-(p-fluorophenyl)-beta,delta-dihydroxy-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)pyrrole-1-heptanoic acid (1:2) | Generator | | Calcium (betar,deltar)-2-(p-fluorophenyl)-β,δ-dihydroxy-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)pyrrole-1-heptanoate (1:2) | Generator | | Calcium (betar,deltar)-2-(p-fluorophenyl)-β,δ-dihydroxy-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)pyrrole-1-heptanoic acid (1:2) | Generator | | Calcium (betar,deltar)-2-(P-fluorophenyl)-b,δ-dihydroxy-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)pyrrole-1-heptanoate (1:2) | Generator | | Calcium (betar,deltar)-2-(P-fluorophenyl)-b,δ-dihydroxy-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)pyrrole-1-heptanoic acid (1:2) | Generator | | Calcium, atorvastatin | MeSH | | Trihydrate, atorvastatin calcium | MeSH | | Atorvastatin calcium trihydrate | MeSH | | Liptonorm | MeSH | | Calcium salt atorvastatin | MeSH | | Anhydrous, atorvastatin calcium | MeSH | | Calcium hydrate, atorvastatin | MeSH | | Calcium trihydrate, atorvastatin | MeSH | | Hydrate, atorvastatin calcium | MeSH | | Atorvastatin calcium anhydrous | MeSH | | Atorvastatin, calcium salt | MeSH | | Calcium anhydrous, atorvastatin | MeSH | | Atorvastatin | MeSH | | Atorvastatin calcium hydrate | MeSH | | (3R,5R)-7-(2-(4-Fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoic acid | MeSH |
|
|---|
| Chemical Formula | C66H68CaF2N4O10 |
|---|
| Average Molecular Mass | 1155.342 g/mol |
|---|
| Monoisotopic Mass | 1154.453 g/mol |
|---|
| CAS Registry Number | 9005-35-0 |
|---|
| IUPAC Name | calcium bis((3R,5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-(propan-2-yl)-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoate) |
|---|
| Traditional Name | calcium bis(atorvastatin(1-)) |
|---|
| SMILES | [Ca++].CC(C)C1=C(C(=O)NC2=CC=CC=C2)C(=C(N1CC[C@@H](O)C[C@@H](O)CC([O-])=O)C1=CC=C(F)C=C1)C1=CC=CC=C1.CC(C)C1=C(C(=O)NC2=CC=CC=C2)C(=C(N1CC[C@@H](O)C[C@@H](O)CC([O-])=O)C1=CC=C(F)C=C1)C1=CC=CC=C1 |
|---|
| InChI Identifier | InChI=1S/2C33H35FN2O5.Ca/c2*1-21(2)31-30(33(41)35-25-11-7-4-8-12-25)29(22-9-5-3-6-10-22)32(23-13-15-24(34)16-14-23)36(31)18-17-26(37)19-27(38)20-28(39)40;/h2*3-16,21,26-27,37-38H,17-20H2,1-2H3,(H,35,41)(H,39,40);/q;;+2/p-2/t2*26-,27-;/m11./s1 |
|---|
| InChI Key | FQCKMBLVYCEXJB-MNSAWQCASA-L |
|---|
| Chemical Taxonomy |
|---|
| Description | belongs to the class of organic compounds known as diphenylpyrroles. These are aromatic heterocyclic compounds with a structure based on a pyrrole ring linked to exactly two phenyl groups. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organoheterocyclic compounds |
|---|
| Class | Pyrroles |
|---|
| Sub Class | Substituted pyrroles |
|---|
| Direct Parent | Diphenylpyrroles |
|---|
| Alternative Parents | |
|---|
| Substituents | - 2,3-diphenylpyrrole
- Aromatic anilide
- Medium-chain hydroxy acid
- Medium-chain fatty acid
- Pyrrole-3-carboxylic acid or derivatives
- Pyrrole-3-carboxamide
- Heterocyclic fatty acid
- Halogenated fatty acid
- Halobenzene
- Fluorobenzene
- Beta-hydroxy acid
- Hydroxy fatty acid
- Aryl halide
- Fatty acid
- Fatty acyl
- Aryl fluoride
- Monocyclic benzene moiety
- Hydroxy acid
- Benzenoid
- Heteroaromatic compound
- Vinylogous amide
- Carboxylic acid salt
- Carboxamide group
- Secondary alcohol
- Secondary carboxylic acid amide
- Organic calcium salt
- Carboximidic acid
- Carboximidic acid derivative
- Organic metal halide
- Carboxylic acid derivative
- Carboxylic acid
- Azacycle
- Organic 1,3-dipolar compound
- Propargyl-type 1,3-dipolar organic compound
- Monocarboxylic acid or derivatives
- Hydrocarbon derivative
- Alcohol
- Organic oxide
- Organopnictogen compound
- Carbonyl group
- Organic salt
- Organic nitrogen compound
- Organic zwitterion
- Organooxygen compound
- Organonitrogen compound
- Organic oxygen compound
- Organohalogen compound
- Organofluoride
- Aromatic heteromonocyclic compound
|
|---|
| Molecular Framework | Not Available |
|---|
| External Descriptors | |
|---|
| Biological Properties |
|---|
| Status | Detected and Not Quantified |
|---|
| Origin | Not Available |
|---|
| Cellular Locations | Not Available |
|---|
| Biofluid Locations | Not Available |
|---|
| Tissue Locations | Not Available |
|---|
| Pathways | Not Available |
|---|
| Applications | Not Available |
|---|
| Biological Roles | Not Available |
|---|
| Chemical Roles | Not Available |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Appearance | Not Available |
|---|
| Experimental Properties | | Property | Value |
|---|
| Melting Point | Not Available | | Boiling Point | Not Available | | Solubility | Not Available |
|
|---|
| Predicted Properties | |
|---|
| Spectra |
|---|
| Spectra | Not Available |
|---|
| Toxicity Profile |
|---|
| Route of Exposure | Not Available |
|---|
| Mechanism of Toxicity | Not Available |
|---|
| Metabolism | Not Available |
|---|
| Toxicity Values | Not Available |
|---|
| Lethal Dose | Not Available |
|---|
| Carcinogenicity (IARC Classification) | Not Available |
|---|
| Uses/Sources | Not Available |
|---|
| Minimum Risk Level | Not Available |
|---|
| Health Effects | Not Available |
|---|
| Symptoms | Not Available |
|---|
| Treatment | Not Available |
|---|
| Concentrations |
|---|
| Not Available |
|---|
| External Links |
|---|
| DrugBank ID | DBSALT000011 |
|---|
| HMDB ID | Not Available |
|---|
| FooDB ID | Not Available |
|---|
| Phenol Explorer ID | Not Available |
|---|
| KNApSAcK ID | Not Available |
|---|
| BiGG ID | Not Available |
|---|
| BioCyc ID | Not Available |
|---|
| METLIN ID | Not Available |
|---|
| PDB ID | Not Available |
|---|
| Wikipedia Link | Atorvastatin |
|---|
| Chemspider ID | Not Available |
|---|
| ChEBI ID | 50686 |
|---|
| PubChem Compound ID | 60822 |
|---|
| Kegg Compound ID | Not Available |
|---|
| YMDB ID | Not Available |
|---|
| ECMDB ID | Not Available |
|---|
| References |
|---|
| Synthesis Reference | Not Available |
|---|
| MSDS | Not Available |
|---|
| General References | Not Available |
|---|